NCT01095653 - A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise | Biotech Hunter

Enrollment

1,179

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions

Type 2 Diabetes

Interventions

DRUG

Dapagliflozin

Tablets, Oral, 5 mg, Once daily, 24 weeks

DRUG

Dapagliflozin

Tablets, Oral, 10 mg, Once daily, 24 weeks

DRUG

Metformin

Tablets, Oral, 500-2000 mg (as needed for rescue based on protocol specific criteria), Up to 20 weeks

DRUG

Dapagliflozin Placebo

Tablets, Oral, 0 mg, Once daily, 24 weeks

Trial Locations (39)

110

Local Institution, Taipei

235

Local Institution, Taipei

402

Local Institution, Taichung

40016

Local Institution, Chongqing

43303

Local Institution, Taichung

71044

Local Institution, Yung Kang City

100029

Local Institution, Beijing

100034

Local Institution, Beijing

100044

Local Institution, Beijing

100730

Local Institution, Beijing

100853

Local Institution, Beijing

110003

Local Institution, Shenyang

130041

Local Institution, Changchun

137040

Local Institution, Seoul

200003

Local Institution, Shanghai

200040

Local Institution, Shanghai

200065

Local Institution, Shanghai

210008

Local Institution, Nanjing

210012

Local Institution, Nanjing

214023

Local Institution, Wuxi

230022

Local Institution, Hefei

300211

Local Institution, Tianjin

302023

Local Institution, Jaipur

310003

Local Institution, Hangzhou

310009

Local Institution, Hangzhou

410000

Local Institution, Changsha

410008

Local Institution, Changsha

430022

Local Institution, Wuhan

430030

Local Institution, Wuhan

452010

Local Institution, Indore

510120

Local Institution, Guanzhou

560043

Local Institution, Bangalore

560092

Local Institution, Bangalore

610072

Local Institution, Chengdu

710032

Local Institution, Xi'an

139-711

Local Institution, Seoul

633-165

Local Institution, Busanjin-gu

471-701

Local Institution, Guri-si

120-752

Local Institution, Seoul